EPHA-mediated growth cone collapse
|
|
|
- ARH12
- ARHA
- FYN
- JTK8
- KIAA0619
- KIAA0866
- KIAA2034
- LYN
- MLC2
- MRLC1
- MRLC2
- MYH10
- MYH11
- MYH14
- MYH9
- MYL12B
- MYL6
- MYL9
- MYLC2B
- MYRL2
- NGEF
- RHO12
- RHOA
- ROCK1
- ROCK2
- YES
- YES1
|
|
EPH-Ephrin signaling
|
|
|
- BSK
- DRT
- ECK
- EEK
- EFL2
- EFL3
- EFNA1
- EFNA2
- EFNA3
- EFNA4
- EFNA5
- EFNB1
- EFNB2
- EFNB3
- EHK1
- EHK2
- EHK3
- ELK
- EPH
- EPHA1
- EPHA10
- EPHA2
- EPHA3
- EPHA4
- EPHA5
- EPHA6
- EPHA7
- EPHA8
- EPHB1
- EPHB2
- EPHB3
- EPHB4
- EPHB6
- EPHT
- EPHT1
- EPHT2
- EPHT3
- EPLG1
- EPLG2
- EPLG3
- EPLG4
- EPLG5
- EPLG6
- EPLG7
- EPLG8
- EPTH3
- ERK
- ETK
- ETK1
- ETK2
- FYN
- HEK
- HEK11
- HEK12
- HEK2
- HEK3
- HEK5
- HEK6
- HEK7
- HEK8
- HTK
- HTKL
- JTK8
- KIAA1459
- LERK1
- LERK2
- LERK3
- LERK4
- LERK5
- LERK6
- LERK7
- LERK8
- LYN
- MYK1
- NET
- SEK
- TNFAIP4
- TYRO1
- TYRO11
- TYRO4
- TYRO5
- TYRO6
- YES
- YES1
|
|
Signaling by ERBB2
|
|
|
- BTC
- CDC37
- CDC37A
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- ERBB2IP
- ERBIN
- EREG
- FYN
- GGF
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRGA
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NDF
- NEU
- NGL
- NRG1
- NRG2
- NRG3
- NRG4
- NTAK
- SMDF
- SRC
- SRC1
- YES
- YES1
|
|
PI3K events in ERBB2 signaling
|
|
|
- BTC
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- EREG
- GAB1
- GGF
- GRB1
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRGA
- MLN19
- NDF
- NEU
- NGL
- NRG1
- NRG2
- NRG3
- NRG4
- NTAK
- PIK3CA
- PIK3R1
- SMDF
|
|
SHC1 events in ERBB2 signaling
|
|
|
- BTC
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- EREG
- GGF
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRAS
- HRAS1
- HRGA
- MLN19
- NDF
- NEU
- NGL
- NRAS
- NRG1
- NRG2
- NRG3
- NRG4
- NTAK
- PKCA
- PKCD
- PKCE
- PRKACA
- PRKCA
- PRKCD
- PRKCE
- PTPN12
- SHC
- SHC1
- SHCA
- SMDF
- SOS1
|
|
GRB2 events in ERBB2 signaling
|
|
|
- BTC
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- EREG
- GGF
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRAS
- HRAS1
- HRGA
- MLN19
- NDF
- NEU
- NGL
- NRAS
- NRG1
- NRG2
- NRG3
- NRG4
- NTAK
- SMDF
- SOS1
|
|
EGFR Transactivation by Gastrin
|
|
|
- DTR
- DTS
- EGFR
- ERBB
- ERBB1
- HBEGF
- HEGFL
- HER1
- HRAS
- HRAS1
- MMP3
- NRAS
- PKCA
- PRKACA
- PRKCA
- SOS1
- STMY1
|
|
PTK6 promotes HIF1A stabilization
|
|
|
- BHLHE78
- BRK
- DTR
- DTS
- EGFR
- ERBB
- ERBB1
- GPNMB
- HBEGF
- HEGFL
- HER1
- HGFIN
- HIF1A
- LRRK2
- MOP1
- NMB
- PARK8
- PASD8
- PTK6
|
|
ERBB2 Regulates Cell Motility
|
|
|
- ARH12
- ARHA
- BTC
- C2orf4
- DIAP1
- DIAPH1
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- EREG
- GGF
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRGA
- MEMO
- MEMO1
- MLN19
- NDF
- NEU
- NGL
- NRG1
- NRG2
- NRG3
- NRG4
- NS5ATP7
- NTAK
- RHO12
- RHOA
- SMDF
|
|
ERBB2 Activates PTK6 Signaling
|
|
|
- BRK
- BTC
- DTR
- DTS
- EGF
- EGFR
- ERBB
- ERBB1
- ERBB2
- EREG
- GGF
- HBEGF
- HEGFL
- HER1
- HER2
- HGL
- HRGA
- MLN19
- NDF
- NEU
- NGL
- NRG1
- NRG2
- NRG3
- NRG4
- NTAK
- PTK6
- SMDF
|
|
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)
|
|
|
|
|
Constitutive Signaling by Overexpressed ERBB2
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HRAS
- HRAS1
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
- NRAS
- PTPN12
- SHC
- SHC1
- SHCA
- SOS1
|
|
Resistance of ERBB2 KD mutants to lapatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to sapitinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to AEE788
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Drug-mediated inhibition of ERBB2 signaling
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to tesevatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Drug resistance in ERBB2 TMD/JMD mutants
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to trastuzumab
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to afatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to neratinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to osimertinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
|
|
|
- EPO
- EPOR
- GAB1
- GRB1
- IRS2
- JAK2
- JTK8
- LYN
- PIK3C1
- PIK3CA
- PIK3CB
- PIK3CD
- PIK3CG
- PIK3R1
- PIK3R5
|
|
Erythropoietin activates STAT5
|
|
|
- EPO
- EPOR
- IRS2
- JAK2
- JTK8
- LYN
- STAT5
- STAT5A
- STAT5B
|
|
Signaling by Erythropoietin
|
|
|
- EPO
- EPOR
- IRS2
- JAK2
- JTK8
- LYN
|
|